| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,510 |
21,507 |
$3.80M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,744 |
15,650 |
$2.54M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,854 |
1,032 |
$1.88M |
| 71045 |
Radiologic examination, chest; single view |
9,718 |
7,505 |
$1.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,453 |
8,047 |
$1.04M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
7,955 |
6,376 |
$917K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,245 |
1,652 |
$846K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,970 |
9,197 |
$777K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,458 |
6,121 |
$516K |
| 90834 |
Psychotherapy, 45 minutes with patient |
7,471 |
4,200 |
$471K |
| A0425 |
Ground mileage, per statute mile |
21,514 |
14,969 |
$458K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
5,318 |
4,091 |
$428K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,262 |
1,973 |
$363K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,234 |
2,440 |
$271K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,893 |
1,456 |
$193K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
3,666 |
1,959 |
$187K |
| 80053 |
Comprehensive metabolic panel |
31,751 |
23,415 |
$183K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,535 |
1,169 |
$164K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,021 |
27,258 |
$159K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,648 |
3,011 |
$155K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,049 |
766 |
$135K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,905 |
1,661 |
$132K |
| 71046 |
Radiologic examination, chest; 2 views |
1,046 |
943 |
$115K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
689 |
274 |
$87K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,713 |
1,178 |
$87K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
372 |
351 |
$78K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,301 |
945 |
$73K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
809 |
198 |
$69K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,939 |
2,687 |
$52K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,444 |
2,060 |
$50K |
| 84484 |
|
5,956 |
4,449 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
24,411 |
18,348 |
$45K |
| 87634 |
|
602 |
529 |
$33K |
| 81025 |
|
5,211 |
3,916 |
$31K |
| 83735 |
|
7,420 |
5,493 |
$26K |
| 99223 |
Prolong inpt eval add15 m |
250 |
185 |
$25K |
| 81001 |
|
13,385 |
10,284 |
$24K |
| 83690 |
|
6,671 |
5,009 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,193 |
3,165 |
$18K |
| 80306 |
|
1,622 |
1,111 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,381 |
1,079 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
698 |
607 |
$13K |
| 87088 |
|
2,513 |
1,924 |
$11K |
| 80061 |
Lipid panel |
1,018 |
823 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
48 |
37 |
$9K |
| 83605 |
|
1,252 |
898 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
710 |
618 |
$8K |
| 90791 |
Psychiatric diagnostic evaluation |
346 |
252 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
353 |
311 |
$7K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
174 |
76 |
$6K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
453 |
134 |
$6K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
221 |
199 |
$6K |
| 99222 |
Initial hospital care, per day, moderate complexity |
67 |
55 |
$5K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
87 |
67 |
$5K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
144 |
119 |
$5K |
| 99221 |
|
88 |
71 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
920 |
778 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
31 |
26 |
$4K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
53 |
39 |
$4K |
| 86140 |
|
778 |
531 |
$3K |
| 80081 |
|
34 |
28 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
276 |
220 |
$2K |
| 81003 |
|
1,411 |
1,169 |
$2K |
| 87040 |
|
130 |
91 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
13 |
$1K |
| 73630 |
|
42 |
37 |
$1K |
| 80055 |
|
32 |
28 |
$1K |
| 83880 |
|
65 |
49 |
$1K |
| 87807 |
|
84 |
77 |
$900.88 |
| 82105 |
|
63 |
51 |
$892.64 |
| 82950 |
|
220 |
185 |
$778.91 |
| 85379 |
|
112 |
84 |
$775.70 |
| 84145 |
|
35 |
25 |
$724.10 |
| 85730 |
|
297 |
239 |
$713.79 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33 |
25 |
$539.01 |
| 85610 |
|
320 |
254 |
$518.46 |
| 87077 |
|
177 |
111 |
$504.72 |
| 84702 |
|
40 |
26 |
$410.76 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
42 |
31 |
$310.75 |
| 84439 |
|
50 |
40 |
$298.65 |
| 80179 |
|
22 |
17 |
$260.97 |
| 80143 |
|
22 |
17 |
$260.97 |
| 86803 |
|
18 |
13 |
$179.80 |
| 87081 |
|
32 |
26 |
$163.77 |
| 80305 |
|
109 |
87 |
$157.07 |
| 87430 |
|
17 |
17 |
$142.47 |
| 83540 |
|
26 |
24 |
$139.75 |
| 83550 |
|
14 |
12 |
$96.14 |
| 80076 |
|
22 |
18 |
$94.29 |
| 82607 |
|
16 |
12 |
$93.93 |
| 84703 |
|
14 |
13 |
$90.24 |
| 87186 |
|
14 |
12 |
$55.92 |
| 87075 |
|
120 |
64 |
$4.48 |
| 87070 |
|
120 |
64 |
$4.26 |
| 87205 |
|
120 |
64 |
$2.02 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
749 |
597 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
36 |
28 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
106 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$0.00 |